Keyvantage Wealth’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.7M Buy
6,225
+373
+6% +$113K 1.02% 20
2026
Q1
$1.25M Buy
5,852
+289
+5% +$64.6K 0.55% 29
2025
Q4
$952K Buy
5,563
+37
+0.7% +$5.75K 0.41% 38
2025
Q3
$740K Sell
5,526
-435
-7% -$46.1K 0.31% 45
2025
Q2
$580K Sell
5,961
-589
-9% -$46.7K 0.26% 54
2025
Q1
$476K Sell
6,550
-414
-6% -$32.6K 0.23% 60
2024
Q4
$503K Buy
+6,964
New +$528K 0.36% 51

Other funds holding LRCX

Keyvantage Wealth's LRCX Position: Q2 2026 in Review

Keyvantage Wealth increased its Lam Research (LRCX) stake by 6.4% in Q2 2026, buying an estimated $113K and bringing the position to 6,225 shares worth $2.7M. The position accounts for 1.02% of the portfolio, ranked #20.

Keyvantage Wealth first reported a position in LRCX in Q4 2024 and has held it in 7 quarters since. 3,130 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Keyvantage Wealth held 6,225 shares of Lam Research worth $2.7M as of Q2 2026.
  • Keyvantage Wealth bought 373 Lam Research shares in Q2 2026, an estimated $113K.
  • Lam Research made up 1.02% of Keyvantage Wealth's portfolio in Q2 2026, its #20 holding.
  • Keyvantage Wealth first reported a position in Lam Research in Q4 2024 and has held it in 7 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Keyvantage Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.